[Ruthenium complexes as antitumor drugs: isolation of a new Ru (III) and iminodiacetic acid complex].
The authors discuss the convenience for using ruthenium complexes as potential antitumor drugs, and the considerable importance of these substances in regard to their biological activity. The synthesis of a new drug of the group and the results of its administration to mice bearing Ehrlich ascites cancer are reported.